If you've got the money to open a premium checking out, you can get some great perks. Check out our list of the best premium ...

AHA letter to the Federal Trade Commission and Department of Justice regarding anticompetitive activity by drug companies with respect to 340B “rebate models.” ...

DESTINY-PanTumor02 is a global, multicenter, multi-cohort, open-label phase 2 trial evaluating the efficacy and safety of ENHERTU (5.4 mg/kg) for the treatment of previously treated HER2 expressing ...

David Knoll has joined Gavin/Solmonese as Senior Consultant, bringing expertise in mergers & acquisitions, commercial banking, and financial management. NEW YORK, NY, UNITED STATES, September 11, 2025 ...

LONDON, GREATER LONDON, UNITED KINGDOM, September 12, 2025 /EINPresswire.com/ -- What Is The Expected Cagr For The Minimally Invasive Gastrointestinal Surgical Systems Market Through 2025? In recent ...